Evidence map›Paper›PMID 42640217›Full record

ArticleEmerging microbes & infections2026

Experimental evolution of phage K enhances antibacterial activity against USA300 MRSA in lung infection models.

Swanti Schapp, Paula Seibold, Yasmina Reisser, Niklas Kühn, Franziska Hornung, Mara Lohde, Christian Brandt, Sandor Nietzsche, Bettina Löffler, Stefanie Deinhardt-Emmer

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Emerging microbes & infections, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Swanti SchappInstitute of Medical Microbiology, Jena University Hospital, Jena, Germany.
Paula SeiboldInstitute of Medical Microbiology, Jena University Hospital, Jena, Germany.
Yasmina ReisserInstitute of Medical Microbiology, Jena University Hospital, Jena, Germany.ORCID 0009-0007-9757-5036
Niklas KühnInstitute of Medical Microbiology, Jena University Hospital, Jena, Germany.
Franziska HornungInstitute of Medical Microbiology, Jena University Hospital, Jena, Germany.ORCID 0000-0002-9942-5572
Mara LohdeInstitute for Infectious Diseases and Infection Control, Jena University Hospital, Jena, Germany.
Christian BrandtInstitute for Infectious Diseases and Infection Control, Jena University Hospital, Jena, Germany.
Sandor NietzscheCentre of Electron Microscopy, Jena University Hospital, Friedrich Schiller University Jena, Jena, Germany.
Bettina LöfflerInstitute of Medical Microbiology, Jena University Hospital, Jena, Germany.
Stefanie Deinhardt-EmmerInstitute of Medical Microbiology, Jena University Hospital, Jena, Germany.ORCID 0000-0003-4495-4052

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hypervirulent community-associated MRSA clones such as

Indexed as

Methicillin-Resistant Staphylococcus aureusPneumonia, StaphylococcalStaphylococcal InfectionsStaphylococcus PhagesA549 CellsAnimalsDisease Models, AnimalFemaleHumansLungMiceantimicrobial resistancebacteriophage Kexperimental evolutionmethicillin-resistant Staphylococcus aureus (MRSA)phage adaptationStaphylococcus aureus USA300

Identifiers

PMID42640217
PMCPMC13552335

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.